APA (7th ed.) Citation

Tunesi, S., Dû, D. L., Gualano, G., Millet, J., Skrahin, A., Bothamley, G., . . . Morel, F. (2022). Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study. The Journal of infection, 84(6), 834-872. https://doi.org/10.1016/j.jinf.2022.03.004

Chicago Style (17th ed.) Citation

Tunesi, Simone, et al. "Co-administration of Treatment for Rifampicin-resistant TB and Chronic HCV Infection: A TBnet and ESGMYC Study." The Journal of Infection 84, no. 6 (2022): 834-872. https://doi.org/10.1016/j.jinf.2022.03.004.

MLA (9th ed.) Citation

Tunesi, Simone, et al. "Co-administration of Treatment for Rifampicin-resistant TB and Chronic HCV Infection: A TBnet and ESGMYC Study." The Journal of Infection, vol. 84, no. 6, 2022, pp. 834-872, https://doi.org/10.1016/j.jinf.2022.03.004.